|Articles|July 9, 2019
Symbio Signs Five-Year Agreement for OmniComm’s TrialMaster
Advertisement
Symbio LLC has announced the signing of a five-year contract with OmniComm Systems, Inc., to use their TrialMaster version 5 to develop and manage clinical study databases.
For more information, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5